CVB homepage

The U.S. Food and Drug Administration (FDA) has cleared the Siemens Healthineers for Syngo.CT Coronary Cockpit, a software system for detailed management of coronary artery disease (CAD) and percutaneous coronary intervention (PCI) planning.

Syngo.CT Coronary Cockpit is an AI-enabled software system built to help improve the management of coronary artery disease and make cath labs more efficient. 

Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.

Researchers explored data from more than 21,000 patients, highlighting the high success rates, low mortality rates and favorable hemodynamic performance of contemporary self-expanding TAVR valves. 

Christopher Kramer, MD, FACC, immediate past president of the American College of Cardiology (ACC), explain the issues the ACC has with the 2027 Medicare Physician Fee Schedule. #AHA2026 #ACC

The group shared several concerns with CMS before the new payment policy was finalized. At the end of the day, however, its message appears to have been largely ignored.

Regularly working a night shift is not directly associated with increased cardiovascular risks. However, it appears to change the heart in ways that are not fully understood. "People who regularly work at night should pay particular attention to looking after their cardiovascular health," one researcher explained. 

Abbott sign at TCT 2023. Photo by Dave Fornell

Abbott built its Encantor Valve and Delivery System with precise deployment and future coronary access in mind. Early data found the new-look TAVR tech to be both safe and effective. 

APQ Health Cedars Sinai developed the AutoPlaque CCTA coronary plaque analysis software, seen here when it was displayed at the SCCT 2026 meeting. Photo by Dave Fornell.

CCTA results pointed to the regression of total plaque volume in 90% of patients who received more aggressive lipid-lowering therapy and 76% of patients who received intensive lipid-lowering therapy. 

Innovation at work

Nearly half of all American adults over the age of 20 have hypertension, and they face an increased risk of cardiovascular disease, renal events and cerebrovascular events. The recent rise of renal denervation has given cardiologists a new way to fight back against this trend.

Sponsored by Recor Medical

Curtiss Stinis, MD, has been performing TAVR for nearly two decades. He says the new policies from CMS that expand coverage for asymptomatic patients represent a "momentous step forward" for heart patients with severe aortic stenosis.